{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:11:28Z","timestamp":1760055088239,"version":"build-2065373602"},"reference-count":136,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.medmal.2006.05.008","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T02:24:55Z","timestamp":1153880695000},"page":"667-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibioth\u00e9rapie des\u00a0pneumonies aigu\u00ebs communautaires \u00e0\u00a0Streptococcus\u00a0pneumoniae\u00a0: impact clinique de\u00a0la\u00a0r\u00e9sistance bact\u00e9rienne"],"prefix":"10.1016","volume":"36","author":[{"given":"J.-P.","family":"B\u00e9dos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2006.05.008_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.112.6.1657","article-title":"Penicillin dosing for pneumococcal pneumonia","volume":"112","author":"Bryan","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\u2013pharmacodynamic parameters: rationale for antibacterial dosing om mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0924-8579(02)00022-5","article-title":"Animal model pharmacokinetics and pharmacodynamics: a critical review","volume":"19","author":"Andes","year":"2002","journal-title":"Int. J. Antibiomicrob. Agents"},{"key":"10.1016\/j.medmal.2006.05.008_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters","volume":"7","author":"Jacobs","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl 36","key":"10.1016\/j.medmal.2006.05.008_bib5","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1183\/09031936.02.00400402","article-title":"Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections","author":"Klugman","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.medmal.2006.05.008_bib6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes fo adult patients with bacteriemic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteriemic pneumococcal pneumonia in the era of the antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"33","author":"Pallares","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"International pneumococcal study group an international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.159.6.9808049","article-title":"Pneumonia acquired in the community through drug-resistant Streptococcus\u00a0pneumoniae","volume":"159","author":"Ewig","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0399-077X(05)80690-0","article-title":"Pneumonies \u00e0 Streptococcus\u00a0pneumoniae de sensibilit\u00e9 diminu\u00e9e \u00e0 la p\u00e9nicilline\u00a0: donn\u00e9es \u00e9pid\u00e9miologiques, facteurs de risque et impact th\u00e9rapeutique","volume":"25","author":"B\u00e9dos","year":"1995","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medmal.2006.05.008_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/598637","article-title":"Penicillin-nonsusceptible Streptococcus\u00a0pneumoniae at San Francisco general hospital","volume":"29","author":"Winston","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/381886","article-title":"Drug-resistant pneumococcal pneumonia: clinical relevance and related factors","volume":"38","author":"Aspa","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/420821","article-title":"Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian network for surveillance of resistant pathogens","volume":"38","author":"Song","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0399-077X(02)00381-5","article-title":"Enqu\u00eate nationale sur les pneumonies communautaires \u00e0 pneumocoques chez des malades adultes hospitalis\u00e9es","volume":"32","author":"Jehl","year":"2002","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medmal.2006.05.008_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteriema in a population with high human immunodeficiency virus seroprevalence","volume":"29","author":"Turett","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.medmal.2006.05.008_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia with especial reference to bacteremie pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib19","series-title":"Clinical relevant of current NCCLS ceftriaxone\u2013cefotaxime resistance breakpoint in non-menigeal pneumococcal infections; 41th ICAAC, abstract L 903","first-page":"460","author":"Pallares","year":"2001"},{"key":"10.1016\/j.medmal.2006.05.008_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/320992","article-title":"Complex relationship between acquisition of \u00df-lactam resistance and loss of virulence in Streptococcus\u00a0pneumoniae","volume":"184","author":"Rieux","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0399-077X(97)80007-8","article-title":"Pharmacodynamie in vitro de l'amoxicilline et bact\u00e9ricidie ex vivo apr\u00e8s 1\u00a0g per os sur Streptococcus\u00a0pneumoniae r\u00e9sistants \u00e0 la p\u00e9nicilline","volume":"27","author":"Jehl","year":"1997","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medmal.2006.05.008_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-3565(24)36381-5","article-title":"Correlation between in vitro et in vivo activity of amoxicillin against Streptococcus\u00a0pneumoniae in a murine pneumonia model","volume":"280","author":"Moine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.medmal.2006.05.008_bib23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0022-3565(24)35213-9","article-title":"Streptococcus\u00a0pneumoniae pneumonia in mice: optimal amoxicillin dosing-predicted from a pharmacokinetic\u2013pharmacodynamic model","volume":"291","author":"Moine","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.medmal.2006.05.008_bib24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.42.9.2375","article-title":"In vivo activities of amoxicillin and amoxicillin\u2013clavulanate against Streptococcus\u00a0pneumoniae: application to breakpoint determinations","volume":"42","author":"Andes","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/AAC.40.4.941","article-title":"Amoxicillin dose-effect relation ship with Streptococcus\u00a0pneumoniae in a mouse pneumonia model roles in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains","volume":"40","author":"Azoulay-Dupuis","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.medmal.2006.05.008_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/AAC.43.1.35","article-title":"Efficacy of high-dose Amoxicillin\u2013Clavulanate against experimental respiratory tract infections caused by strains of Streptococcus\u00a0pneumoniae","volume":"43","author":"Woodnutt","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib27","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.43.10.2484","article-title":"Development of a new experimental model of penicillin-resistant Streptococcus\u00a0pneumonia and amoxicillin treatment by reproducing human pharmacokinetics","volume":"43","author":"Piroth","year":"1999","journal-title":"Antimicrob. Agents Chemothe"},{"key":"10.1016\/j.medmal.2006.05.008_bib28","unstructured":"B\u00e9dos JP, Moniot-Ville N, Bouvier d'Yvoire M, Azoulay-Dupuis E, Carbon C. Efficacy of cefotaxime in a murine model of penicillin-resistant pneumococcal pneumonia, with simulation of human pharmacokinetics. 38th ICAAC 1998; San Diego USA (Abstract A 128)."},{"key":"10.1016\/j.medmal.2006.05.008_bib29","unstructured":"Abgueguen P, B\u00e9dos JP, Dautrey S, Rieux V, Carbon C, Azoulay-Dupuis E. Amoxicillin remains effective against highly penicillin-resistant Streptococcus\u00a0pneumoniae at dosing regimens simulating human pharmacokinetics in a mouse pneumonia model. 38th ICAAC 1998; San Diego USA (Abstract A 131)."},{"key":"10.1016\/j.medmal.2006.05.008_bib30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.38.9.1953","article-title":"In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and resistant strains of Streptococcus\u00a0pneumoniae in a mouse pneumonia model","volume":"38","author":"Moine","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-077X(97)80008-X","article-title":"Exp\u00e9rience clinique du traitement par l'amoxicilline des pneumonies \u00e0 pneumocoques de sensibilit\u00e9 diminu\u00e9e \u00e0 la p\u00e9nicilline G","volume":"27","author":"B\u00e9dos","year":"1997","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medmal.2006.05.008_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000114817.58194.BF","article-title":"Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality","volume":"32","author":"Lujan","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus\u00a0pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2004.03.008","article-title":"A review of clinical failures associated with macrolide-resistant Streptococcus\u00a0pneumoniae","volume":"24","author":"Rzeszutek","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.medmal.2006.05.008_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/344965","article-title":"Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy","volume":"36","author":"Butler","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrugresistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0732-8893(02)00379-6","article-title":"Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus\u00a0pneumoniae resistant to macrolides by a 23S rRNA mutation","volume":"43","author":"Smith","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kays","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","article-title":"Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams","volume":"51","author":"Van Kerkhoven","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib41","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.118.6.1839-a","article-title":"Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy","volume":"118","author":"Waterer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/341980","article-title":"In vivo veritas: in vitro macrolide resistance in systemic Streptococcus\u00a0pneumoniae infections does result in clinical failure","volume":"35","author":"Jacobs","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"suppl. 1","key":"10.1016\/j.medmal.2006.05.008_bib43","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant. Streptococcus\u00a0pneumoniae for community-acquired pneumonia (CAP)","volume":"34","author":"Lynch","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/321868","article-title":"Bacteremia and meningitis caused by a macrolide-sensitive stain of Streptococcus\u00a0pneumoniae during treatment with azithromycin","volume":"33","author":"Lisby","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib45","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/AAC.46.12.4029-4034.2002","article-title":"Pharmacodynamic modelling of clarithromycin against macrolide-resistant (PCR positive mef A or erm B) Streptococcus\u00a0pneumoniae simulating clinically achievable free drug serum and epithelial lining fluid (ELF) concentrations","volume":"46","author":"Noreddin","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02116528","article-title":"Failure of pristinamycin treatment in a case of pneumococcal pneumonia","volume":"14","author":"Burucoa","year":"1995","journal-title":"Eur. J. Clin Micobiol. Infect. Dis."},{"issue":"suppl. 4","key":"10.1016\/j.medmal.2006.05.008_bib47","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/382694","article-title":"Quinolone resistance among pneumococci: therapeutic and diagnostic implications","volume":"38","author":"Low","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus\u00a0pneumoniae in Hong-Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/AAC.46.2.522-524.2002","article-title":"Selection of Streptococcus\u00a0pneumoniae mutants having reduced susceptibility to moxifloxacine and levofloxacine","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus\u00a0pneumoniae to fluoroquinolone in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib51","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.45.10.2793-2797.2001","article-title":"Pharmacodynamics of fluoroquinolones against Streptococcus\u00a0pneumoniae in patients with community-acquired respiratory tract infections","volume":"45","author":"Ambrose","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1086\/376642","article-title":"Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia","volume":"37","author":"Anderson","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.10229","article-title":"Levofloxacin failure in a patient with pneumococcal pneumonia","volume":"35","author":"Empey","year":"2001","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.medmal.2006.05.008_bib55","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3201\/eid0909.020810","article-title":"Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates","volume":"9","author":"Perez-Trallero","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1473-3099(01)00090-1","article-title":"Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes","volume":"1","author":"Tillotson","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib57","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/323086","article-title":"Fluoroquinolone-resistant Streptococcus\u00a0pneumoniae associated with levofloxacin therapy","volume":"184","author":"Urban","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/322658","article-title":"A nosocomial outbreak of fluoroquinolone-resistant Streptococcus\u00a0pneumoniae","volume":"33","author":"Weiss","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib59","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-131-4-199908170-00023","article-title":"Fluoroquinolone resistance in Streptococcus\u00a0pneumoniae","volume":"131","author":"Kuehnert","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM200207043470115","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"347","author":"Ross","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib61","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/0140-6736(92)91560-U","article-title":"Penicillin-resistant pneumococci and community-acquired pneumonia","volume":"339","author":"Sanchez","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.05.008_bib62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1086\/319222","article-title":"Risk factors for acquisition of levofloxacin-resistant Streptococcus\u00a0pneumoniae: a case control study","volume":"32","author":"Ho","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-3565(24)37553-6","article-title":"Pharmacodynamic activities of ciprofloxacine and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy","volume":"286","author":"B\u00e9dos","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.medmal.2006.05.008_bib64","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/344768","article-title":"Widespread use of fluoroquinolones vs emerging resistance in pneumococci","volume":"35","author":"Ellie","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/378809","article-title":"Gatifloxacin, Gemifloxacin, and Moxifloxacin: the role of 3 never fluoroquinolones","volume":"37","author":"Saravolatz","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jama.283.6.749","article-title":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia. Capital study investigators. Community-acquired pneumonia intervention trial assessing levofloxacin","volume":"283","author":"Marrie","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2006.05.008_bib67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-142-3-200502010-00006","article-title":"Outpatient care compared with hospitalisation for community-acquired pneumonia. A randomized trial in low-risk patients","volume":"142","author":"Carratal\u00e0","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib68","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1378\/chest.124.2.526","article-title":"An economic evaluation of sequential IV\/PO Co-amoxiclav with or without Clarithromycin in the treatment of community-acquired pneumonia","volume":"124","author":"Drummond","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib69","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremie pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978\u20131997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib70","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremie pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib71","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u00df-lactam based empirical regimen is associated with lower in hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib73","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial threrapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch. Intern."},{"key":"10.1016\/j.medmal.2006.05.008_bib74","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.123.5.1503","article-title":"Impact of initial antibiotic choice on clinical outcomes in community acquired pneumonia: analysis of a hospital claims made database","volume":"123","author":"Brown","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1345\/aph.19174","article-title":"Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of non teaching US community hospitals","volume":"34","author":"Dudas","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.medmal.2006.05.008_bib76","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib77","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1378\/chest.119.5.1420","article-title":"Empiric antibiotic therapy and mortality among Medicare pneumonia in patients in 10 western states: 1993, 1995, and 1997","volume":"119","author":"Houck","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib78","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/archinte.159.21.2576","article-title":"Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia","volume":"159","author":"Stahl","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib79","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0149-2918(00)80059-4","article-title":"Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia","volume":"22","author":"Burgess","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.medmal.2006.05.008_bib80","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00134-002-1325-3","article-title":"Association between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-asquired pneumonia","volume":"28","author":"Rello","year":"2002","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib81","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/archinte.159.21.2511","article-title":"The best treatment for pneumonia","volume":"159","author":"Dowell","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib82","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-002-1324-4","article-title":"How do we optimize outcomes for patients with severe community-acquired pneumonia?","volume":"28","author":"Niederman","year":"2002","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib83","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(02)08250-8","article-title":"Severe pneumonia and a second antibiotic","volume":"359","author":"Macfarlane","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.medmal.2006.05.008_bib84","first-page":"1329","article-title":"FCCP, Pert, WA, Australia. Combination antibiotic therapy with macrolides in community-acquired Pneumonia","volume":"123","author":"Grant","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib85","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/367545","article-title":"What is optimal antimicrobial therapy for bacteremie pneumococcal pneumoniae?","volume":"36","author":"File","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib86","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkg413","article-title":"How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review","volume":"52","author":"Oosterheert","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib87","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1378\/chest.128.2.940","article-title":"FCCP. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia","volume":"128","author":"Weiss","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.medmal.2006.05.008_bib88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1378\/chest.128.1.10","article-title":"Monotherapy in severe community-acquired pneumonia. Is it worthy?","volume":"128","author":"Torres","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib89","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Uptade of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian infectious diseases Society and the canadian thoracic Society. The Canadian community-acquired pneumonia working group","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib91","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2006.05.008_bib92","first-page":"IV1","article-title":"British Guidelines for the management of community acquired pneumonia in adults","volume":"56","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2006.05.008_bib93","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1378\/chest.125.5.1888","article-title":"Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia","volume":"125","author":"File","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib94","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1183\/09031936.98.11040986","article-title":"Guidelines for management of adult community-acquired lower respiratory tract infections","volume":"11","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.medmal.2006.05.008_bib95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0399-077X(01)00197-4","article-title":"What should the initial antibiotherapy for acute community-acquired pneumonia be? How should it be reassessed in case of failure, given the evolution of responsible pathogens and the resistance of pneumococci? Should combined treatment be used?","volume":"31","year":"2001","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medmal.2006.05.008_bib96","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/AAC.40.9.2147","article-title":"Synergy between amoxicillin and gentamicin in combination against highly penicillin-resistant and tolerant strain of Streptococcus\u00a0pneumoniae in a mouse pneumoniae model","volume":"40","author":"Darras-Joly","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib97","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/AAC.40.4.941","article-title":"Amoxicillin dose-effect relationship with Streptococcus\u00a0pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains","volume":"40","author":"Azoulay-Dupuis","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1469-0691.2002.00477.x","article-title":"Antibiotic toleranc in pneumococci","volume":"8","author":"Normak","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.medmal.2006.05.008_bib99","first-page":"552","article-title":"Clinical isolates of Streptococcus\u00a0pneumoniae exhibiting decreased killing by vancomycin","volume":"32","author":"Normak","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.medmal.2006.05.008_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/315216","article-title":"Isolation and characterization of vancomycin-tolerant Streptococcus\u00a0pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis","volume":"181","author":"McCullers","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10096-003-1032-1","article-title":"Multicentre study of the molecular epidemiology serotypes and antimicrobial susceptibility patterns of invasive Streptococcus\u00a0pneumoniae invasive isolated from children in the Ile de France area","volume":"23","author":"Decousser","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib102","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JCM.37.10.3380-3383.1999","article-title":"Antibiotic susceptibilities of group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes","volume":"37","author":"Zaoutis","year":"1999","journal-title":"Clin Microbiol"},{"key":"10.1016\/j.medmal.2006.05.008_bib103","first-page":"69","article-title":"Bacterial endocarditis due to a penicillin-tolerant group C.\u00a0streptococcus","volume":"122","author":"Portnoy","year":"1980","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.medmal.2006.05.008_bib104","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJM199505113321907","article-title":"The pathogenesis of pneumococcal infection","volume":"332","author":"Tuomanen","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/arrd.1987.135.4.869","article-title":"Induction of pulmonary inflammation by components of the pneumococcal cell surface","volume":"135","author":"Tuomanen","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/infdis\/158.1.36","article-title":"Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci","volume":"158","author":"Tuomane","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib107","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00134-002-1330-6","article-title":"Clinical implications of antiobiotic-induced endotoxin release in septic shock","volume":"28","author":"Lepper","year":"2002","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib108","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/155.5.985","article-title":"Non steroidal anti-inflammatory agents in the therapy of experimental pneumococcal meningitis","volume":"155","author":"Tuomanen","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib109","first-page":"197","article-title":"The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin","volume":"98","author":"Wagner","year":"1956","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"10.1016\/j.medmal.2006.05.008_bib110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.medmal.2006.05.008_bib111","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","article-title":"Antagonism betxeen penicillin and erythromycin against Streptococcus\u00a0pneumoniae in vitro and in vivo","volume":"46","author":"Krogh Johansen","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib112","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.05.008_bib113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/thx.51.2.179","article-title":"Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients","volume":"51","author":"Lieberman","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2006.05.008_bib114","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/thorax.56.4.296","article-title":"Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines","volume":"56","author":"Lim","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2006.05.008_bib115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/00365540410020127","article-title":"Diagnosis of typical pathogens in patients hospitalized with community-acquired respiratory infection","volume":"36","author":"Schneeberger","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib116","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/341771","article-title":"Legionnaires disease with bacteremic coinfection","volume":"35","author":"Tan","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib117","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bmj.38334.591586.82","article-title":"Effectriveness of \u00df-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis","volume":"330","author":"Mills","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2006.05.008_bib118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.128.1.172","article-title":"Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors","volume":"128","author":"Leroy","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib119","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"long-term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.05.008_bib120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2006.05.008_bib121","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.medmal.2006.05.008_bib122","first-page":"1113","article-title":"Effect of erythromycin on Haemophilus\u00a0influenzae endotoxin-induced release of IL-6, IL-8, and sICAM-1 by cultured human bronchial epithelial cells","volume":"14","author":"Khair","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.medmal.2006.05.008_bib123","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0924-8579(98)00091-0","article-title":"Effect of clarithromycin and azithromycin on production of cytokines by human monocytes","volume":"11","author":"Khan","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.medmal.2006.05.008_bib124","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.43.4.907","article-title":"Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors","volume":"43","author":"Kohyama","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/24.4.561","article-title":"Comparison of the in vitro effect of several macrolides on the oxidative burst of human neutrophils","volume":"24","author":"Labro","year":"1989","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib126","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/AAC.39.4.872","article-title":"Erythromycin shortens neutrophil survival by accelerating apoptosis","volume":"39","author":"Aoshiba","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.05.008_bib127","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1378\/chest.107.5.1342","article-title":"Patterns of cytokine expression in community-acquired pneumonia","volume":"107","author":"Puren","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.05.008_bib128","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.02.00295102","article-title":"Systemic cytokine levels in community-acquired pneumonia and their associations with disease severity","volume":"20","author":"Antunes","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2006.05.008_bib129","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1086\/382689","article-title":"Monotherapy vs dual therapy for community-acquired pneumonia in hospitalized patients","volume":"38","author":"Martinez","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib130","unstructured":"Noel V, Bedos JP, Brudy L, Carbon Cl, Azoulay-Dupuis E. Comparative activity of vancomycine and teicoplanine in mouse pneumonia model induced by highly penicillin and cefotaxime resistant strains of Streptococcus\u00a0pneumoniae. 37th ICAAC 1997, Toronto, Canada (Abstract B4)."},{"key":"10.1016\/j.medmal.2006.05.008_bib131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of \u00df-lactam: risk factors for carriage of penicillin-resistant Streptococcus\u00a0pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2006.05.008_bib132","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1086\/421354","article-title":"Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia","volume":"39","author":"Thomas","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib133","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course Levofloxacin for community-acquired pneumonia: a new treatment paradigm","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.05.008_bib134","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.1.31","article-title":"Antibiotic therapy of community respiratory tract infections\u00a0: strategies for optimal outcomes and minimized resistance emergence","volume":"49","author":"Ball","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"19","key":"10.1016\/j.medmal.2006.05.008_bib135","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chaftre","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2006.05.008_bib136","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1164\/ajrccm\/147.1.38","article-title":"Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia","volume":"147","author":"Montravers","year":"1993","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X06001363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X06001363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:05:46Z","timestamp":1759971946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X06001363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":136,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0399077X06001363"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2006.05.008","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibioth\u00e9rapie des\u00a0pneumonies aigu\u00ebs communautaires \u00e0\u00a0Streptococcus\u00a0pneumoniae\u00a0: impact clinique de\u00a0la\u00a0r\u00e9sistance bact\u00e9rienne","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2006.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}